Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Clinical trial NCT00039481 · COMPLETED

Trial details

NCT number: NCT00039481
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiac Toxicity Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2002-11-01
Primary completion: 2005-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.